61 results on '"Gerbes, Alexander L."'
Search Results
2. Pretreatment with zinc protects Kupffer cells following administration of microbial products
3. Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl4 mouse model
4. The effects of hepatic steatosis on thromboxane A2 induced portal hypertension
5. The effects of hepatic steatosis on thromboxane A2 induced portal hypertension
6. Evaluating the best empirical antibiotic therapy in patients with acute-on-chronic liver failure and spontaneous bacterial peritonitis
7. Development and Validation of a Test to Identify Drugs That Cause Idiosyncratic Drug-Induced Liver Injury
8. Herbal tea and liver injury – Tea extract or comedication can make a difference
9. Mitochondrial adaptation in steatotic mice
10. Data on chow, liver tissue and mitochondrial fatty acid compositions as well as mitochondrial proteome changes after feeding mice a western diet for 6–24 weeks
11. Diagnosis and treatment of ascites
12. Tapering of Immunosuppression and Sustained Treatment With Nivolumab in a Liver Transplant Recipient
13. Targeting cyclin dependent kinase 5 in hepatocellular carcinoma – A novel therapeutic approach
14. Erratum to “The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure” [J Hepatol 2015;62:831–840]
15. The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure
16. Role of cysteinyl-leukotrienes for portal pressure regulation and liver damage in cholestatic rat livers
17. Functional relevance of the cannabinoid receptor 2 — heme oxygenase pathway: A novel target for the attenuation of portal hypertension
18. High age and low sodium urine concentration are associated with poor survival in patients with hepatorenal syndrome
19. Human monocyte-derived cells with individual hepatocyte characteristics: a novel tool for personalized in vitro studies
20. Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis
21. Terlipressin for Hepatorenal Syndrome: Continuous Infusion as an Alternative to IV Bolus Administration
22. Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A2
23. The patient with refractory ascites
24. P60-c-src suppresses apoptosis through inhibition of caspase 8 activation in hepatoma cells, but not in primary hepatocytes
25. Characterization of organic anion transporter regulation, glutathione metabolism and bile formation in the obese Zucker rat
26. Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: A safe and effective therapy?
27. Protein kinase A dependent signalling mediates anti-apoptotic effects of the atrial natriuretic peptide in ischemic livers
28. Atrial natriuretic peptide preconditioning protects against hepatic preservation injury by attenuating necrotic and apoptotic cell death
29. Treatment of Crigler-Najjar type 1 disease: relevance of early liver transplantation
30. Kupffer-cell specific induction of heme oxygenase 1 (hsp32) by the atrial natriuretic peptide — role of cGMP
31. Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: A randomized double-blind multicenter trial
32. Reply
33. Atrial natriuretic peptide reduces expression of TNF-α mRNA during reperfusion of the rat liver upon decreased activation of NF-κB and AP-1
34. Preservation injury of the liver: mechanisms and novel therapeutic strategies
35. Successful treatment of chronic Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt
36. Reply
37. Malignant Liver Tumors - Current and Emerging Theories
38. Glutathione protects the rat liver against reperfusion injury after hypothermic preservation
39. The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver
40. Medical care of the transplant patient
41. Diseases of the Gastrointestinal Tract and Liver
42. Daily profile of plasma endothelial-1 and -3 in pre-ascitic cirrhosis: relationships with the arterial pressure and renal functin
43. Quantitative discrimination of ANF receptor subtypes in portal hypertension
44. The kidney in liver disease
45. Endothelin-1 and endothelin-3 in cirrhosis: Relations to systemic and splanchnic haemodynamics
46. Prolonged antagonism of α1-Adrenergic vasoconstriction in the rat liver by atrial natriuretic peptide
47. Differentiation of endothelin-1 and endothelin-3 concentrations
48. Reply
49. Azygos and hepatic extraction of atrial natriuretic factor (ANF) in patients with cirrhosis no evidence of reduced disposal
50. Medical treatment of ascites in cirrhosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.